Reinforced biographies among women living with hepatitis C

Qualitative Health Research

Volumn 23, Issue 4, 2013, Pages 531-540

  Olsen, Anna ^a   Banwell, Cathy ^b   Dance, Phyll ^b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

addiction substance use; biographical analysis; hepatitis C; illness and disease, chronic; illness and disease, experiences; illness and disease, social construction; lay concepts and practices; social equality inequality

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; DISEASE TRANSMISSION; FEMALE; HEPATITIS C; HUMAN; INTERVIEW; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; SUBSTANCE ABUSE; CLINICAL TRIAL; PSYCHOLOGY; TRANSMISSION;

ADULT; AUSTRALIA; FEMALE; HEPATITIS C; HUMANS; INTERVIEWS AS TOPIC; SUBSTANCE ABUSE, INTRAVENOUS; WOMEN;

EID: 84874454306     PISSN: 10497323     EISSN: 15527557     Source Type: Journal    
DOI: 10.1177/1049732312469730     Document Type: Article

References (68)

1. Amin J., O'Connell D., Bartlett M., Tracey E., Kaldor J., Law M., Dore G.. Liver cancer and hepatitis B and C in New South Wales, 1990-2002: A linkage study. Australia and New Zealand Journal of Public Health. 2007 ; 31 (5). 475-482 (Pubitemid 47629025)
2. The young women injecting drug users' project final report. Canberra, ACT, Australia: AIVL ; 2004 :
3. Bibeau G.. At work in the fields of public health: The abuse of rationality. Medical Anthropology Quarterly. 1997 ; 11 (2). 246-252
4. Bolam B., Hodgetts D., Chamberlain K., Murphy S., Gleeson K.. 'Just do it': An analysis of accounts of control over health amongst lower socioeconomic status groups. Critical Public Health. 2003 ; 13 (1). 15-31 (Pubitemid 36511500)
5. Bury M.. Chronic illness as biographical disruption. Sociology of Health and Illness. 1982 ; 5: 168-195
6. Bury M. Health and illness. Cambridge, UK: Polity Press ; 2005 :
7. Carricaburu D., Pierret J.. From biographical disruption to biographical reinforcement: The case of HIV-positive men. Sociology of Health and Illness. 1995 ; 17 (1). 65-88
8. Carrier N., Laplante J., Bruneau J.. Exploring the contingent reality of biomedicine: Injecting drug users, hepatitis C and risk. Health, Risk and Society. 2005 ; 7 (2). 123-140 (Pubitemid 40796998)
9. Commonwealth of Australia. (2010). Third national hepatitis C strategy 2010-2013. Retrieved from http://www.health.gov.au/internet/main/publishing.nsf/ Content/ohp-national-strategies-2010-hcv/$File/hcv.pdf
10. Conrad S., Garrett L., Cooksley W., Dunne M., MacDonald G.. Living with chronic hepatitis C means 'you just haven't got a normal life any more'. Chronic Illness. 2006 ; 2 (2). 121-131 (Pubitemid 44014758)
11. Copeland L.. The drug user's identity and how it relates to being hepatitis C antibody positive: A qualitative study. Drugs: Education, Prevention and Policy. 2004 ; 11 (2). 129-147 (Pubitemid 38472494)
12. Corbin J., Strauss A. L. Unending work and care: Managing chronic illness at home. San Francisco: Jossey-Bass ; 1988 :
13. Cornberg M., Wedemyer H., Manns M.. Treatment of chronic hepatitis C with pegylated interferon and ribavirin. Current Gastroenterology Reports. 2002 ; 4: 23-30
14. Cornwall J. Hard-earned lives: Accounts of health and illness from East London. London: Tavistock ; 1984 :
15. Coughlan B., Sheehan J., Hickey A., Crowe J.. Psychological well-being and quality of life in women with an iatrogenic hepatitis C virus infection. British Journal of Health Psychology. 2002 ; 7: 105-116 (Pubitemid 34174903)
16. Dalgard O., Bjøro K., Hellum K., Myrvang B., Skaug K., Gutigard B.. Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up. European Addiction Research. 2002 ; 8 (1). 45-49 (Pubitemid 34701984)
17. Davis M., Rhodes T.. Beyond prevention?: Injecting drug user narratives about hepatitis C. International Journal of Drug Policy. 2004a ; 15: 123-131 (Pubitemid 38373951)
18. Davis M., Rhodes T.. Managing seen and unseen blood associated with drug injecting: Implications for theorising harm reduction for viral risk. International Journal of Drug Policy. 2004b ; 15: 377-384 (Pubitemid 39488227)
19. Davis M., Rhodes T., Martin A.. Preventing hepatitis C: 'Common sense,' 'the bug' and other perspectives from the risk narratives of people who inject drugs. Social Science and Medicine. 2004 ; 59 (9). 1807-1818 (Pubitemid 39093782)
20. Davison C., Smith G. D., Frankel S.. Lay epidemiology and the prevention paradox: The implications of coronary candidacy for health education. Sociology of Health and Illness. 2008 ; 13 (1). 1-19
21. Edlin B. R., Seal K. H., Lorvick J., Kral A. H., Ciccarone D. H., Moore L. D.. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?. New England Journal of Medicine. 2001 ; 345: 211-214 (Pubitemid 32662133)
22. El-SeragH. B. (2002). Hepatocellular carcinoma: An epidemiologic view. Journal of Clinical Gastroenterology, 35(5, Suppl. 2), S72-S78. Retrieved from http://journals.lww.com/jcge/Fulltext/2002/11002/Hepatocellular-Carcinoma-An- Epidemiologic-View.2.aspx (Pubitemid 35278644)
23. Ezzy D. Second opinion: An introduction to health sociology. Germov J., ed. Melbourne, Australia: Oxford University Press ; 2005 :
24. Faircloth C. A., Boylstein C., Rittman M., Ellen Young M., Gubrium J.. Sudden illness and biographical flow in narratives of stroke recovery. Sociology of Health & Illness. 2004 ; 26 (2). 242-261 (Pubitemid 38507307)
25. Farmer P.. Bad blood, spoiled milk: Bodily fluids as moral barometers in rural Haiti. American Ethnologist. 1988 ; 15 (1). 62-83
26. Faye B., Irurita V. F.. Balancing perspective: The response to feelings of being condemned with the hepatitis C virus. Journal of Substance Use. 2003 ; 8 (2). 92-103 (Pubitemid 36889622)
27. Fraser S., Treloar C.. 'Spoiled identity' in hepatitis C infection: The binary logic of despair. Critical Public Health. 2006 ; 16 (2). 99-110 (Pubitemid 44659282)
28. Gifford S., O'Brien M., Bammer G., Banwell C., Stoové M.. Australian women's experiences of living with hepatitis C virus: Results from a cross-sectional survey. Journal of Gastroenterology and Hepatology. 2003 ; 18 (7). 841-850 (Pubitemid 36936578)
29. Glacken M., Kernohan G., Coates V.. Diagnosed with hepatitis C: A descriptive exploratory study. International Journal of Nursing Studies. 2001 ; 38: 107-116 (Pubitemid 33660481)
30. Hardey M. The social context of health. Buckingham, UK: Open University Press ; 1998 :
31. Harris M.. Troubling biographical disruption: Narratives of unconcern about hepatitis C diagnosis. Sociology of Health & Illness. 2009 ; 31 (7). 1028-1042
32. HopwoodM.TreloarC. (2003). The 3D Project: Diagnosis, disclosure, discrimination and living with hepatitis C (Monograph 6/2003). Sydney, Australia: University of New South Wales. Retrieved from http://nchsr.arts.unsw. edu.au/media/File/3Dproject.pdf
33. Hopwood M., Treloar C., Bryant J.. Hepatitis C and injecting-related discrimination in New South Wales, Australia. Drugs: Education, Prevention & Policy. 2006 ; 13 (1). 61-75 (Pubitemid 43663701)
34. Keeley B., Wright L., Condit C.. Functions of health fatalism: Fatalistic talk as face saving, uncertainty management, stress relief and sense making. Sociology of Health & Illness. 2009 ; 31 (5). 734-747
35. Kelly M. P., Field D.. Medical sociology, chronic illness and the body. Sociology of Health and Illness. 1996 ; 18 (2). 241-257
36. Krug G. J.. Hepatitis C: Discursive domains and epistemic chasms. Journal of Contemporary Ethnography. 1995 ; 24: 299-322 (Pubitemid 126006483)
37. Lambert H., McKevitt C.. Anthropology in health research: From qualitative methods to multidisciplinarity. British Medical Journal. 2002 ; 325: 210-213 (Pubitemid 34827897)
38. Lupton D. Medicine as culture. London: Sage ; 1994 :
39. Maher L.. Don't leave us this way: Ethnography and injecting drug use in the age of AIDS. International Journal of Drug Policy. 2002 ; 13: 311-325 (Pubitemid 35284592)
40. Marmot M.. Social determinants of health inequalities. Lancet. 2005 ; 365 (9464). 1099-1104 (Pubitemid 40386787)
41. MielckA.Backett-MilburnK.PavisS. (1998). Perception of health inequalities in different social classes, by health professionals and health policy makers in Germany and in the United Kingdom. Retrieved from http://bibliothek.wzb.eu/pdf/1998/p98-202.pdf
42. MuhrT.FrieseS. (2004). User's manual for ATLAS.ti 5.0. Retrieved from http://downloads.atlasti.com/atlman.pdf
43. Najman J.. Health and poverty: Past, present and prospects for the future. Social Science and Medicine. 1993 ; 36 (2). 157-166
44. National Centre in HIV Epidemiology and Clinical Research. (2010). HIV, viral hepatitis and sexually transmissible infections in Australia. Annual Surveillance Report. Retrieved from http://www.med.unsw.edu.au/nchecrweb.nsf/ resources/SurvRep07/$file/ASR2010-rev1.pdf
45. O'Brien S., Day C., Black E., Dolan K.. Injecting drug users' understanding of hepatitis C. Addictive Behaviours. 2008 ; 33 (12). 1602-1605
46. Olsen A., Banwell C., Dance P., Maher L.. Positive health beliefs and behaviours in the midst of difficult lives: Women who inject drugs. International Journal of Drug Policy. 2012 ; 23: 312-318
47. Parsons T. The social system. London: Routledge & Kegan Paul ; 1951 :
48. Pill R., Scott N.. Choice or chance: Further evidence on ideas of illness and responsibility of health. Social Science and Medicine. 1985 ; 20: 981-991 (Pubitemid 15229946)
49. Radley A.. Style, discourse and constraint in adjustment to chronic illness. Sociology of Health & Illness. 2008 ; 11 (3). 230-252
50. Razali K., Thein H. H., Bell J., Cooper-Stanbury M., Dolan K., Dore G., Law M.. Modelling the hepatitis C virus epidemic in Australia. Drug and Alcohol Dependence. 2007 ; 91 (2-3). 228-235 (Pubitemid 47539727)
51. Rhodes T., Davis M., Judd A.. Hepatitis C and its risk management among drug injectors in London: Renewing harm reduction in the context of uncertainty. Addiction. 2004 ; 99 (5). 621-633 (Pubitemid 38561426)
52. Rhodes T., Treloar C.. The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction. 2008 ; 103: 1593-1603
53. Richmond J. A., Dunning T. L., Desmond P. V.. Health professionals' attitudes toward caring for people with hepatitis C. Journal of Viral Hepatitis. 2007 ; 14 (9). 624-632 (Pubitemid 47258264)
54. Roy E., Nonn E., Haley N., Cox J.. Hepatitis C meanings and preventative strategies among street-involved young injection drug users in Montreal. International Journal of Drug Policy. 2007 ; 18: 397-405 (Pubitemid 47374504)
55. Scheper-Hughes N., Lock M.. The mindful body: A prolegomenon to future work in medical anthropology. Medical Anthropology Quarterly. 1987 ; 1 (1). 6-41
56. Scrambler G.. Health-related stigma. Sociology of Health & Illness. 2009 ; 31 (3). 441-455
57. Southgate E., Weatherall A., Day C., Dolan K.. What's in a virus? Folk understandings of hepatitis C infection and infectiousness among injecting drug users in Kings Cross, Sydney. International Journal for Equity in Health. 2005 ; 4: 5-10
58. Spiegel B., Younossi Z., Hays R., Revicki D., Robbins S., Kanwal F.. Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment. Hepatology. 2005 ; 41 (4). 790-800 (Pubitemid 40462941)
59. Temple-Smith M., Jenkinson K., Lavery J., Gifford S., Morgan M.. Discrimination or discretion? Exploring dentist's views on treating patients with hepatitis C. Australian Dental Journal. 2006 ; 51 (4). 318-323
60. Treloar C., Rhodes T.. The lived experience of hepatitis C and its treatment among injecting drug users: Qualitative synthesis. Qualitative Health Research. 2009 ; 19: 1321-1334
61. Ville I., Khlat M.. Meaning and coherence of self and health: An approach based on narratives of life events. Social Science & Medicine. 2007 ; 64: 1001-1014 (Pubitemid 46098983)
62. Walker C., Peterson C.. Contextuallsing indicators of socio-economic status: Chronic illness as lived experience of SES. Australian Journal of Primary Health. 2003 ; 9 (2&3). 141-147 (Pubitemid 38133133)
63. Williams S. J.. Theorising class, health and lifestyles: Can Bourdieu help us?. Sociology of Health and Illness. 1995 ; 17 (5). 577-604
64. Williams S. J.. Chronic illness as biographical disruption or biographical disruption as chronic illness? Reflections on a core concept. Sociology of Health and Illness. 2000 ; 22 (1). 40-67
65. Williams S. J. Medicine and the body. London: Sage ; 2005 :
66. Wilson S.. 'When you have children, you're obliged to live': Motherhood, chronic illness and biographical disruption. Sociology of Health & Illness. 2007 ; 29: 610-626
67. Wozniak L., Prakash M., Taylor M., Wild C.. Everybody's got it, but...: Situational and strategic participation in normalized HCV discourse among injection drug users in Edmonton, Canada. International Journal of Drug Policy. 2007 ; 18: 388-396 (Pubitemid 47374505)
68. Zickmund S., Ho E. Y., Masuda M., Ippolito L., LaBrecque D. R.. "They treated me like a leper": Stigmatization and the quality of life of patients with hepatitis C. Journal of General Internal Medicine. 2003 ; 18: 835-844 (Pubitemid 37281779)